Enhertu Uni Eropa - Belanda - EMA (European Medicines Agency)

enhertu

daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplasmata van de borst - antineoplastische middelen - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Vanflyta Uni Eropa - Belanda - EMA (European Medicines Agency)

vanflyta

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemie, myeloïde - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Logroton Divitabs 200 mg - 25 mg tabl. verl. afgifte Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

logroton divitabs 200 mg - 25 mg tabl. verl. afgifte

sankyo pharma belgium sa-nv - chloortalidon 25 mg; metoprololtartraat 200 mg - tablet met verlengde afgifte - 200 mg - 25 mg - chloortalidon 25 mg; metoprololtartraat 200 mg - chlortalidone; c07ab02 metoprolol; c07cb02 metoprolol and other diuretics

Lomir 2,5 mg omh. tabl. Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lomir 2,5 mg omh. tabl.

sankyo pharma belgium sa-nv - isradipine 2,5 mg - tablet - 2,5 mg - isradipine 2.5 mg - isradipine

Lomir Retard 5 mg harde caps. verl. afgifte Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lomir retard 5 mg harde caps. verl. afgifte

sankyo pharma belgium sa-nv - isradipine 5 mg - capsule met verlengde afgifte, hard - 5 mg - isradipine 5 mg - isradipine

Lopresor 100 mg tabl. Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lopresor 100 mg tabl.

sankyo pharma belgium sa-nv - metoprololtartraat 100 mg - tablet - 100 mg - metoprololtartraat 100 mg - metoprolol

Olmetec 10 mg filmomh. tabl. Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

olmetec 10 mg filmomh. tabl.

sankyo pharma belgium sa-nv - olmesartanmedoxomil 10 mg - filmomhulde tablet - 10 mg - olmesartanmedoxomil 10 mg - olmesartan medoxomil

Olmetec 20 mg filmomh. tabl. Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

olmetec 20 mg filmomh. tabl.

sankyo pharma belgium sa-nv - olmesartanmedoxomil 20 mg - filmomhulde tablet - 20 mg - olmesartanmedoxomil 20 mg - olmesartan medoxomil

Olmetec 40 mg filmomh. tabl. Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

olmetec 40 mg filmomh. tabl.

sankyo pharma belgium sa-nv - olmesartanmedoxomil 40 mg - filmomhulde tablet - 40 mg - olmesartanmedoxomil 40 mg - olmesartan medoxomil

Prareduct 10 mg tabl. Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prareduct 10 mg tabl.

sankyo pharma belgium sa-nv - pravastatinenatrium 10 mg - tablet - 10 mg - pravastatinenatrium 10 mg - pravastatin